CTRI/2017/09/009658
Not yet recruiting
Phase 2
Efficacy of Neoadjuvant chemotherapy in carcinoma esophagus A pilot study comparing Cisplatin plus 5FU with Paclitaxel plus Carboplatin
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Carcinoma esophagus
- Sponsor
- ALL INDIA INSTITUTE OF MEDICAL SCIENCES
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age \<70 years
- •2\. Squamous cell carcinoma of esophagus and gastroesophageal junction
- •3\. Good performance status\- ECOG (Eastern cooperative oncology group) 0,1 and 2
- •4\. Imaging suggests potentially operable cases (Up to T4a stage)
Exclusion Criteria
- •1\. Medically inoperable cases like poor performance status ECOG \>2
- •2\. Gross tumor infiltration in to the mediastenal structure like\- tracheal infiltration, large contact with aorta, atrium involvement
- •3\. Cases with distant Metastasis
- •4\. Carcinoma involving cervical esophagus
- •5\. Patient who have already received radiotherapy or chemotherapy
- •6\. Patient refused for consent for the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Efficacy and safety of neoadjuvant chemotherapy by S-1 plus cisplatin for Stage III esophageal squamous cell carcinoma: A phase II trialEsophageal squamous cell carcinomaJPRN-UMIN000014707agoya University Hospital30
Recruiting
Not Applicable
Prospective study of neoadjuvant chemotherapy with FEC100x4 for BRCAness cases in triple negative breast cancerBreast cancerJPRN-UMIN000029433Tokyo medical university70
Completed
Not Applicable
Effect of neoadjuvant chemotherapy in patients with gastric cancerIRCT2015020220906N1Vice chancellor for Research and Technology30
Completed
Not Applicable
A Prospective Study of Neoadjuvant Chemotherapy with Nivolumab/Gemcitabine/Cisplatin in Muscle-Invasive or Locally-Advanced Urothelial Carcinoma of BladderKCT0003804Samsung Medical Center48
Recruiting
Phase 1
Phase I, II study of neoadjuvant chemotherapy with gemcitabine and nab-paclitaxel for resectable pancreatic cancerpancreatic ductal cancerJPRN-jRCTs021200003Ishido Keinosuke30